MicroRNA-22 Regulates the Pro-inflammatory Responses and M1 Polarization of Macrophages by Targeting GLUT1 and 4-1BBL
Journal of Immunology Research · 10.07.2023 · 2023 · 1-12
DOI: 10.1155/2023/2457006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, erschienen am 10.07.2023. Verfasst von Young Jun Kang. Beteiligte Einrichtung: Molecular Medicine Research Institute, Sunnyvale, CA 94085, USA. Hauptthemen laut MEDLINE: 4-1BB Ligand, MicroRNAs. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, U.S. Department of Health and Human Services.
Abstract (Originalsprache)
Many microRNAs (miRNAs) are selectively expressed in mammalian immune cells and have been linked to immune responses in host defense and autoimmune disease. In macrophages, miRNAs regulate cell metabolism by repressing the expression of genes such as transcription factors, enzymes, and metabolism-related molecules, as well as the expression of genes that impact inflammatory responses and phenotype determination. Previous studies showed that miR-22 plays a role in a variety of biological processes, such as cancer cell growth, cell survival, and cell expansion. In CD4 + T cells of inflammatory bowel disease patients, miR-22 is upregulated and regulates inflammasome-mediated responses. However, it has not yet been determined how miR-22 contributes to the activation of innate immune cells. In this study, we identified a mechanism of toll-like receptors- (TLR-) dependent miR-22 induction that regulates the downstream signaling pathway linking inflammatory responses and macrophage polarization. MiR-22 is induced via TLR-signaling, which regulates the induction of Slc2a1 (glucose transporter 1 and Glut1) and Tnfsf9 (tumor necrosis factor 9, 4-1BB ligand, and 4-1BBL) mRNAs that contribute to sustained inflammatory responses and the polarization of macrophages. Our observations support further efforts to explore a potential therapeutic strategy using miR-22 for the modulation of excessive macrophage activation for the treatment of inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular Medicine Research Institute, Sunnyvale, CA 94085, USA.
ORCID-Profile: Young Jun Kang
Förderung
- NIAID NIH HHS
- National Institutes of Health
- U.S. Department of Health and Human Services
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Kang, Y. J. (2023). MicroRNA-22 Regulates the Pro-inflammatory Responses and M1 Polarization of Macrophages by Targeting GLUT1 and 4-1BBL. Journal of Immunology Research, 2023, 1-12. https://doi.org/10.1155/2023/2457006
Vancouver
Kang YJ. MicroRNA-22 Regulates the Pro-inflammatory Responses and M1 Polarization of Macrophages by Targeting GLUT1 and 4-1BBL. Journal of Immunology Research. 2023;2023:1-12. doi:10.1155/2023/2457006
BibTeX
@article{Kang2023,
author = {Kang, Young Jun},
title = {MicroRNA-22 Regulates the Pro-inflammatory Responses and M1 Polarization of Macrophages by Targeting GLUT1 and 4-1BBL},
journal = {Journal of Immunology Research},
year = {2023},
volume = {2023},
pages = {1--12},
doi = {10.1155/2023/2457006}
}
EUVIMED